Role(s) in Healthcare Innovation:
Entrepreneur Healthcare Innovator InvestorMy Communities
NOLA Health Innovators Global Healthcare Innovation AMIADaniel Rothman, ScB in Cognitive Neuroscience, MBA Healthcare
VP of Corporate Strategy / COO
New York, NY United States
About Me
Daniel Rothman joined Mymee first as an advisor. He soon fell in love with the product and mission and decided to come on board full time. While finishing his undergrad at Brown University, he co-founded Zeo, a sleep technology company. While completing his Healthcare Executive MBA; he launched another business, PeraHealth, a life-saving EMR application that identifies patient health trends. Since he joined CityMD in 2012, Daniel has grown it from 4 locations to 56 and secured $95M in funding.
Interested in solutions for:
For my portfolio I am working on a great new idea for healthcareI am looking for healthcare innovations:
Alternative Therapies Clinical Interventions Diagnostics Fitness or Wellness Healthy Living Home-Based Care Hospital Solutions Managed Care Pain Management Patient Power Tools! Prevention Regenerative Medicine Wearables
by
Andre Berger
Excellence in Value Based Care
by Andre Berger
by
Daniel Rothman
Personal Health Coach
by Daniel Rothman
by
Nik Tehrani
Advanced Health Assessment & Management for Preventive Care
by Nik Tehrani
You have not backed any projects.
Lets change that!
Discover Projects
No comments on any project yet.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.